Drug General Information
Drug ID
D0D7XM
Former ID
DIB002150
Drug Name
NC-4016
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [524551]
Company
Nanocarrier
Target and Pathway
Target(s) Human DNA Target Info Inhibitor [544448]
References
Ref 524551ClinicalTrials.gov (NCT01999491) A Phase 1 Dose-Escalation and Pharmacokinetic Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma. U.S. National Institutes of Health.
Ref 544448Effects of Treatment with Platinum Azidothymidine and Azidothymidine on Telomerase Activity and Bcl-2 Concentration in Hepatocellular Carcinoma- Induced Rats. Avicenna J Med Biotechnol. 2014 Oct-Dec;6(4): 200-209.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.